Figure 3

Use of secondary prevention drugs after first myocardial infarction in combinations of two, three, four or five agents including acetylsalicylic acid, angiotensin-converting enzyme inhibitors or angiotensin-2 receptor blockers, β-blockers, clopidogrel, and statins, respectively, claimed ≤90 days after discharge during the period 2003–2006. DM: diabetes mellitus.